Following Pfizer’s acquisition, Biohaven’s valuation skyrocketed under Vlad Coric. Find out why BHVN stock’s growth potential ...

Patients with CKD have a 56% higher prevalence of severe mental health disorders such as schizophrenia, bipolar disorder, or ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

Schizophrenia and major depressive disorder (MDD) may be genetically associated with increased risk for constipation but only the latter association appears to be clinically significant, according to ...

Fiancé star Larissa Dos Santos Lima has been diagnosed with major depressive disorder and is stepping away from social media. A rep for the reality star, 38, named Julia Dickson, announced the news on ...

Mice resilient to stress had more CB1 receptors in the BBB than mice with depressive-like behavior or mice not exposed to stress.

The following is a summary of “Spaced Transcranial Direct Current Stimulation for Major Depression,” published in the January ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a generative AI software leader in clinical trial analytics, announces its funded collaboration with ...

Upping your physical activity level may lower your risk of developing neuropsychiatric diseases such as anxiety, depression ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Compass Pathways gains Stifel's Buy rating as its COMP360 psilocybin treatment advances in Phase 3 trials. Key depression study data expected in 2025-2026.